Ultra-sensitive ctDNA analysis, tailored to your needs

PERSONALIZED assays – PERSONALIZED service

Personalization

Tumor-informed vs. tumor-naïve

Versatility and flexibility

Patient stratification. ctDNA informed chemotherapy.

Corporate

1 Min Read

We are pleased to announce that our CEO, Pontus Rehn, will represent Simsen Diagnostics at the upcoming ...

April 14, 2025 11:14:02 AM CEST

Corporate

1 Min Read

Simsen Diagnostics is excited to announce its participation in the upcoming Swiss Nordic Bio 2025 conference, ...

February 26, 2025 5:21:49 PM CET

Customer

2 Min Read

Gothenburg, 21 February 2025 Simsen Diagnostics Partners with Buzzard Pharmaceuticals for Isunakinra ...

February 21, 2025 3:14:17 PM CET

Corporate

2 Min Read

Gothenburg 2024-10-25: Simsen Diagnostics has signed an agreement with Docrates, a private cancer center in ...

October 25, 2024 9:45:00 AM CEST